Search This Blog

Wednesday, January 15, 2020

ChromaDex announces regulatory approvals of Tru Niagen

ChromaDex (NASDAQ:CDXC) announces the approval of dietary ingredient Tru Niagen (nicotinamide riboside chloride) in Australia and the European Union.
The product has market exclusivity in the former until December 2021 and the latter until February 2025.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)